Select the type of procedure
21425522
1
Enquiry period
with
27.05.2025 17:43
to 06.06.2025 15:00
to 06.06.2025 15:00
8 days left
2
Bidding period
with
06.06.2025 15:00
to 05.08.2025 14:00
to 05.08.2025 14:00
3
Auction
will not be used
4
Evaluation
5
Contract
Status
Enquiry period
Estimated value without VAT
3 505 011,55 MDL
Period of clarifications:
27 May 2025, 17:43 - 6 Jun 2025, 15:00
Submission of proposals:
6 Jun 2025, 15:00 - 5 Aug 2025, 14:00
Supplier technical support:
(+373) 79999801
This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.
Subscribe impossible
during the period Enquiry period
“Achiziționarea medicamentelor necesare instituțiilor medico-sanitare publice (IMSP) și instituțiilor bugetare care prestează servicii medicale și sociale pentru anul 2026 (Lista suplimentară nr. 2)”
Information about customer
Fiscal code/IDNO
Address
MD-2005, MOLDOVA, mun.Chişinău, locality, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2
Web site
---
The contact person
Purchase data
Date created
27 May 2025, 17:34
Date modified
28 May 2025, 8:37
Achizitii.md ID
21425522
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 14 - Dapagliflozinum (cu 3 indicatii conform RCP) 10 mg
Budget: 490475.0 MDL
Active
Lot nr. 15 - Dapagliflozinum (cu indicatie doar in Diabet zaharat tip 2 conform RCP) 10 mg
Budget: 2970.83 MDL
Active
Lot nr. 17 - D-fructose-1,6-diphosphate sodium salt hydrate 5 g/50 ml
Budget: 67327.83 MDL
Active
Lot nr. 21 - Ferri (III) hydroxidum cum polymaltosi complexum 50 mg/ml 30 ml
Budget: 4636.8 MDL
Active
Lot nr. 39 - Linkus balsam (sau echivalentul din punct de vedere calitativ si cantitativ) 25 g
Budget: 226.0 MDL
Active
Lot nr. 40 - Lipiodol Ultra Fluid (sau echivalentul) 480 mg iod/ml 10 ml
Budget: 311111.11 MDL
Active
Lot nr. 41 - Lisinoprilum + Amlodipinum + Indapamidum 10 mg+5 mg+1,5 mg
Budget: 478.48 MDL
Active
Lot nr. 42 - Lisinoprilum + Amlodipinum + Indapamidum 20 mg+10 mg+1,5 mg
Budget: 547.17 MDL
Active
Lot nr. 44 - Metamizoli natrium + Pitofenonum + Fenpiverini bromidum 500 mg+2 mg+0.02 mg/ml 5 ml
Budget: 5406.11 MDL
Active
Lot nr. 47 - Olmesartanum medoxomilum+ Amlodipinum+ Hydrochlorothiazidum 40 mg+10 mg+12,5 mg
Budget: 1000.19 MDL
Active
Lot nr. 48 - Olmesartanum medoxomilum+Amlodipinum+ Hydrochlorothiazidum 40 mg+10 mg+25 mg
Budget: 1083.33 MDL
Active
Lot nr. 51 - Paracetamolum+ Caffeinum+ Phenylephrinum hydrochloridum+ Chlorpheniramini maleas 500 mg+ 30 mg+10 mg+2 mg (analog Gripgo)
Budget: 6944.44 MDL
Active
Lot nr. 54 - Pikovit (sau echivalentul din punct de vedere calitativ si cantitativ) 150 ml
Budget: 1328.4 MDL
Active
Lot nr. 55 - Povidoni iodidum (solutie nestandardizata de Povidon-iod) 100 mg/ml 50 ml
Budget: 1000.0 MDL
Active
Lot nr. 56 - Povidoni iodidum (solutie nestandardizata de Povidon-iod) 100 mg/ml 500 ml
Budget: 10000.0 MDL
Active
Lot nr. 58 - Prostamed (sau echivalentul din punct de vedere calitativ si cantitativ) -
Budget: 2170.89 MDL
Active
Lot nr. 60 - Salmeterolum+Fluticasonum 25 mcg+250 mcg/doza 120 doze
Budget: 14135.5 MDL
Active
Lot nr. 61 - Tenofoviri disoproxilum/Tenofoviri disoproxili fumaras 245 mg sau 300 mg
Budget: 178.5 MDL
Active
Documents of the procurement procedure
Anunt de participare din 27.05.2025 LS2.signed
Bidding Documents
Anunt de participare din 27.05.2025 LS2.signed
27.05.25 17:43
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
27.05.25 17:43
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
27.05.25 17:43
Documentatia standard din 27.05.2025 LS2.signed
Bidding Documents
Documentatia standard din 27.05.2025 LS2.signed
27.05.25 17:43
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
27.05.25 17:43
Lista de distributie_LS nr. 2_Med pu 2026
Bidding Documents
Lista de distributie_LS nr. 2_Med pu 2026
27.05.25 17:43
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK